Iwasaki K, Oida I, Usami A, Hashimoto Y, Yamada M, Ozawa T
Dept. of Otolaryngology, Hamamatsu Medical Center.
Gan To Kagaku Ryoho. 1999 Feb;26(3):369-72.
A patient with early laryngeal cancer who rejected both radiation therapy and surgery was treated with only chemotherapy of UFT combined with CBDCA. UFT (tegafur 300 mg/day) was administered orally and CBDCA was injected intravenously at a dose of 300 mg/body every 1-2 months, 11 times. For over 2 years the patient has demonstrated gradual tumor growth, but has not complained of dyspnea and has worked every day. The chemotherapy has improved his quality of life.
一名早期喉癌患者拒绝放疗和手术,仅接受了优福定联合卡铂的化疗。优福定(替加氟300毫克/天)口服给药,卡铂静脉注射,剂量为300毫克/体,每1 - 2个月注射1次,共11次。两年多来,患者肿瘤逐渐生长,但未出现呼吸困难症状,且每天都能工作。化疗改善了他的生活质量。